We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

CEPHEID

Develops, manufactures, and markets molecular systems and tests for institutions to perform sophisticated genetic tes... read more Featured Products: More products

Download Mobile App




Unique Gene Detects Mycobacterium Tuberculosis in Clinical Sputum

By LabMedica International staff writers
Posted on 13 Oct 2021
Tuberculosis (TB) is a common infectious disease caused by Mycobacterium tuberculosis (MTB). More...
The main organ infected by MTB is the lung, but many other tissues or organs can be affected, such as the bone and pleura. Two million people die of MTB infection each year due to poor quality of life and lack of awareness.

An early and accurate diagnosis of TB is the critical factor for controlling and effectively treating the epidemic. Molecular detection, sputum-smear microscopy, and culture-based methods are widely used to diagnose TB in the clinic. The benefits of molecular diagnosis are rapidity, specificity, and high sensitivity.

Health Scientists at the Kunming University of Science and Technology (Kunming, China) collected a total of 232 clinical sputum samples from TB patients by physicians from January 2019 to December 2020. Sputum from all patients was subjected to the BACT MGIT-960 test (Becton-Dickinson, Brea, CA, USA) and Gene Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA, USA).

A total of 173 genome sequences of Mycobacterium were downloaded and analyzed and a specific MTB gene was selected. The TB18.5 gene was considered a specific gene of the MTB strains and TB18.5 primers were designed. One-step PCR was performed in a 20 µL reaction volume, including 3 µL of DNA extracted from sputum, 10 µl of 2× TSINGKE Master Mix, and 0.3 µM each of the myco-F1 and myco-R1 primers and nested PCR was also performed. Six common clinical pathogens were used as negative controls to investigate the specificity of the TB18.5 gene and the primers.

The investigators reported that the results showed that 195 (84.05%), 182 (78.45%), and 162 (69.83%) samples were identified as MTB using nested PCR, the Gene Xpert MTB/RIF assay, and the BACTEC MGIT-960 CULTURE test, respectively. Although the nested PCR-positive ratio was the highest among the three methods, no statistical difference was identified between results of nested PCR and Gene Xpert MTB/RIF assay. However, there were significant difference between results of BACTEC MGIT-960 CULTURE test and nested PCR or Gene Xpert MTB/RIF assay.

The authors concluded that the TB18.5 gene, which was identified as a unique gene in MTB strains, was used to evaluate MTB infections. The optimized nested PCR/nested qRT-PCR method was established to detect MTB in clinical sputum samples, which showed higher positive ratio than Xpert MTB/RIF assay and the BACTEC MGIT-960 CULTURE test. Therefore, it is benefit for TB patients to obtain early and sensitively diagnose and treatment by using this nest-PCR method. The study was published on September 30, 2021 in the Journal of Clinical Laboratory Analysis.

Related Links:
Kunming University of Science and Technology
Becton-Dickinson
Cepheid



New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Portable Electronic Pipette
Mini 96
New
ESR Analyzer
TEST1 2.0
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The nanotechnology-based liquid biopsy test could identify cancer at its early stages (Photo courtesy of 123RF)

2-Hour Cancer Blood Test to Transform Tumor Detection

Glioblastoma and other aggressive cancers remain difficult to control largely because tumors can recur after treatment. Current diagnostic methods, such as invasive biopsies or expensive liquid biopsies,... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.